| Serial Number | 79417612 |
| Word Mark | CORXEL |
| Filing Date | Sunday, September 29, 2024 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Wednesday, March 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Anti-inflammatories; cardiovascular pharmaceutical preparations; antibiotics; medicines for human purposes, namely, medicines for the treatment of degenerative disease, motor neuron disease; medicines for human purposes, namely, medicines for the treatment of epilepsy; medicines for human purposes, namely, medicines for the treatment of macular degeneration; medicines for human purposes, namely, medicines for the treatment of cardiovascular disease, coronary heart disease, angina pectoris, myocarditis, cardiac arrhythmia, tumors, infectious diseases, autoimmune disease, blood disease, mental illness, ophthalmic disorders, metabolic diseases and disorders in the nature of diabetes, kidney diseases, osteoporosis; antiviral medicines; antibiotics and bacterial poisons; medicines for human purposes, namely, biological products, prepared by using biological materials in the nature of microorganisms, cells, and various animal and human tissues and liquids, obtained by biological techniques, namely, genetic engineering, cell engineering, protein engineering, fermentation engineering for the treatment of central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, antipyretic and analgesic purposes, non-steroidal anti-inflammatory purposes, infectious diseases, autoimmune diseases, anti-tumor purposes, hypoglycemic and diuretic purposes, vitamin and hormonal purposes; medicines for human purposes, namely, parenteral nutrition supplements; pharmaceutical preparations acting on the central nervous system; preparations for destroying parasites; cerebral hemorrhage prophylactic agents; pharmaceutical preparations for the treatment of heart rhythm disorders; antiarrhythmics; antiparasitic preparations; cardiovascular agents for medical purposes; nutritive substances for microorganisms for medical purposes; nutritive substances for microorganism cultures for medical or veterinary purposes; pharmaceutical preparations for treating hypertension; nasal spray preparations; ophthalmic preparations; eye drops; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; raw material drugs, namely, pharmaceuticals for the treatment of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; antihypertensives; diuretic preparations; medicines for the treatment of cardiovascular and cerebrovascular diseases; dietetic preparations adapted for medical purposes; dietetic foods and beverages adapted for medical use; dietetic infusions for medical use; biocides; acaricides; cotton for medical purposes; wipes impregnated with disinfectants for hygiene purposes; eyepatches for medical purposes. |
| Goods and Services | Wholesale and retail store services featuring sanitary preparations; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale and retail store services featuring medical supplies; wholesale and retail store services featuring medicines; wholesale and retail store services featuring pharmaceutical preparations. |
| Goods and Services | Monitoring pharmaceutical, veterinary and sanitary preparations, medical supplies and drug for quality control purposes; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; scientific research and development; chemical research services; pharmaceutical research services; scientific research in the nature of conducting clinical trials for others in the field of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research in the field of inflammation, cardiovascular diseases, heart failure, cardiac arrhythmia, coronary heart disease, angina pectoris, myocarditis, hypertension, central nervous system diseases, cerebral hemorrhage, cerebral infarction, metabolic diseases and disorders in the nature of diabetes, kidney diseases, tumors, parasitosis, acariasis, bacterial infection, fungal infection, microbiosis, ophthalmic disorders, rhinopathy, edema, cirrhosis ascites; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical product evaluation for laboratory purposes; testing of pharmaceuticals for laboratory purposes; packaging design. |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 14, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 14, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 14, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ji Xing Pharmaceuticals (Shanghai) Co., |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, February 20, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 14, 2025 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, March 14, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 14, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 19, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, March 19, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, March 20, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |